文献速递生殖医学

子宫内膜异位症患者再次IVF前地诺孕素预处理的研究

Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.
PubMed 文献 · Reprod Biomed Online · 2020-07-26

本研究基于前瞻性收集数据库的回顾性分析,纳入151例既往一次IVF失败且影像学诊断子宫内膜异位症的女性,比较直接IVF与地诺孕素(DNG)2 mg/日预处理3个月后IVF的结局。DNG组累积着床率、临床妊娠率和活产率显著高于未治疗组,且子宫内膜瘤最大直径显著缩小,在子宫内膜瘤直径≥4 cm者中获卵数、双原核胚胎数和囊胚数显著增加。

要点

  • DNG预处理3个月后IVF的累积着床率、临床妊娠率、活产率显著高于未治疗组。
  • DNG预处理后子宫内膜瘤最大直径显著缩小(P < 0.001)。
  • 子宫内膜瘤直径≥4 cm者中,DNG显著增加获卵数、双原核胚胎数和囊胚数。

核心结论

  • 作者认为,子宫内膜异位症患者通过DNG预处理可改善IVF结局,尤其在大子宫内膜瘤患者中可获得更好的获卵和囊胚。

研究设计与样本

  • 基于前瞻性收集数据库的回顾性分析,纳入151例既往一次IVF失败且影像学诊断子宫内膜异位症的女性,比较直接IVF与DNG 2 mg/日预处理3个月后IVF的结局。

主要发现

  • 88例(58.3%)未接受激素治疗直接IVF,63例(41.7%)接受DNG预处理。
  • DNG组累积着床率39.7% vs 未治疗组23.9%(P = 0.049),临床妊娠率33.3% vs 18.2%(P = 0.037),活产率28.6% vs 14.8%(P = 0.043),DNG组均显著更高。
  • DNG预处理后子宫内膜瘤最大直径显著缩小(P < 0.001)。
  • 子宫内膜瘤直径≥4 cm者中,DNG显著增加获卵数(P = 0.031)、双原核胚胎数(P = 0.039)和囊胚数(P = 0.005)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The major causes of IVF failure in women with endometriosis have been attributed to decreased ovarian reserve, low embryo quality and impaired receptivity of the endometrium. Dienogest (DNG) has anti-inflammatory and anti-angiogenic activity and so may theoretically improve IVF outcomes in women with endometriosis. This study aimed to evaluate the administration of DNG before IVF in women with endometriosis who had previously failed one IVF cycle. METHODS: This study was based on the retrospective analysis of a prospectively collected database, including 151 women who had failed a previous IVF cycle and all subsequent embryo transfers and had an imaging diagnosis of endometriosis. Patients either directly underwent IVF without receiving hormonal treatment or received 3 months of treatment with DNG (2 mg/daily) before IVF. RESULTS: Eighty-eight (58.3%) patients underwent IVF without previous hormonal treatment, and 63 (41.7%) received pretreatment with DNG. The cumulative implantation, clinical pregnancy and live birth rates were significantly higher in the DNG-treated group (39.7%, 33.3% and 28.6%) than in the non-treated group (23.9%, 18.2% and 14.8%; P = 0.049, 0.037 and 0.043, respectively). The largest diameter of endometriomas significantly decreased after DNG pretreatment (P < 0.001). The use of DNG increased significantly the number of oocytes retrieved (P = 0.031), two-pronuclear embryos (P = 0.039) and blastocysts (P = 0.005) in women with endometriomas of diameter ≥4 cm. CONCLUSIONS: This study suggest that in patients with endometriosis, IVF outcomes can be improved by pretreatment with DNG. In particular, the use of DNG allows for better oocyte retrieval and blastocysts in patients with large endometriomas.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Barra F, Laganà AS, Scala C, et al. Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reprod Biomed Online. 2020. PMID: 32873492. doi:10.1016/j.rbmo.2020.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。